drugset / Trial / NCT00227812

Integrated Treatment for Cocaine and Mood Disorders - 1

NCT00227812

Phase 2 Completed 140 enrolled National Institute on Drug Abuse (NIDA)
RandomizedSingle-groupDouble-blindTreatment

Summary

The purpose of this study is to test whether cognitive behavioral therapy and bupropion hydrochloride will help cocaine users, who are depressed, reduce or end their cocaine use and improve their mood.

Timeline

Start
2001-04
Primary completion
2005-12
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule